Oragenics Initiates Safety Study of Novel Treatment to Prevent Tooth Decay

Oragenics has begun a Phase I clinical study of its Replacement Therapy, a novel approach to the prevention of tooth decay.

The study, being conducted in six couples and an additional nine individuals at Hill Top Research in West Palm Beach, Fla., will look at the safety of Replacement Therapy and the potential for horizontal transmission of the Replacement Therapy organism to the nontreated member of each couple.